Ignite Creation Date:
2024-05-06 @ 12:38 PM
Last Modification Date:
2024-10-26 @ 1:02 PM
Study NCT ID:
NCT03816306
Status:
COMPLETED
Last Update Posted:
2020-01-18
First Post:
2019-01-22
Brief Title:
Six Months Clinical and Echocardiographic Outcome of ARNI LCZ696 Therapy in HFrEF Patients
Sponsor:
Mohammed Alnims
Organization:
Cairo University
Study Overview
Official Title:
Six Months Clinical and Echocardiographic Outcome of Angiotensin Receptor-Neprilysin Inhibitor ARNI LCZ696 Therapy in Heart Failure Patients With Reduced Ejection Fraction HFrEF
Status:
COMPLETED
Status Verified Date:
2020-01
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
To evaluate the clinical and echocardiographic outcome of LCZ696 therapy in HFrEF NYHA Class II - IV and EF 40patients in addition to the efficacy of LCZ696 in reducing mortality and rehospitalisation rate
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
True
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
False
Is an FDA AA801 Violation?:
None